Advertisement
Screener

AGENUS INC (AGEN) Increase (Decrease) in Other Operating Assets and Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

AGENUS INC Increase (Decrease) in Other Operating Assets and Liabilities, Net

AGENUS INC (AGEN) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $1.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-07

  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was $541.00K.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $706.00K.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$10.04M.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was $11.18M.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $198.00K, a 71.35% decline from fiscal 2024.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $691.00K, a 55.28% decline from fiscal 2023.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $1.54M.
  • AGENUS INC increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$13.94M.
Period endIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed
2026-06-30$541.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$1.25M
10-Q · filed 2026-08-07
-$8.80M
derived: sum of 3 quarters · filed 2026-08-07
$2.39M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$706.00K
10-Q · filed 2026-05-11
-$9.34M
derived: sum of 2 quarters · filed 2026-05-11
$1.84M
derived: sum of 3 quarters · filed 2026-05-11
$1.28M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$10.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$1.14M
derived: sum of 2 quarters · filed 2026-03-16
$571.00K
derived: sum of 3 quarters · filed 2026-08-07
$198.00K
10-K · filed 2026-03-16
2025-09-30$11.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$10.62M
derived: sum of 2 quarters · filed 2026-08-07
$10.24M
10-Q · filed 2025-11-10
$10.04M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$568.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$941.00K
10-Q · filed 2026-08-07
-$1.14M
derived: sum of 3 quarters · filed 2026-08-07
-$1.69M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$373.00K
10-Q · filed 2026-05-11
-$575.00K
derived: sum of 2 quarters · filed 2026-05-11
-$1.13M
derived: sum of 3 quarters · filed 2026-05-11
-$91.00K
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$202.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$753.00K
derived: sum of 2 quarters · filed 2026-03-16
$282.00K
derived: sum of 3 quarters · filed 2026-03-16
$691.00K
10-K · filed 2026-03-16
2024-09-30-$551.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$484.00K
derived: sum of 2 quarters · filed 2025-11-10
$893.00K
10-Q · filed 2025-11-10
$1.32M
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$1.44M
10-Q · filed 2025-08-11
$1.87M
derived: sum of 3 quarters · filed 2026-03-16
-$2.08M
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31$409.00K
10-Q · filed 2025-05-12
$832.00K
derived: sum of 2 quarters · filed 2026-03-16
-$3.11M
derived: sum of 3 quarters · filed 2026-03-16
-$572.00K
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31$423.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
-$3.52M
derived: sum of 2 quarters · filed 2026-03-16
-$981.00K
derived: sum of 3 quarters · filed 2026-03-16
$1.54M
10-K · filed 2026-03-16
2023-09-30-$3.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$1.40M
derived: sum of 2 quarters · filed 2024-11-12
$1.12M
10-Q · filed 2024-11-12
$1.74M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$5.07M
10-Q · filed 2024-08-08
$5.69M
derived: sum of 3 quarters · filed 2025-03-17
$6.23M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31$2.53M
10-Q · filed 2024-05-07
$3.15M
derived: sum of 2 quarters · filed 2025-03-17
$3.69M
derived: sum of 3 quarters · filed 2025-03-17
-$6.70M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31$621.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$1.16M
derived: sum of 2 quarters · filed 2025-03-17
-$9.22M
derived: sum of 3 quarters · filed 2025-03-17
-$13.94M
10-K · filed 2025-03-17
2022-09-30$538.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$9.84M
derived: sum of 2 quarters · filed 2023-11-09
-$14.56M
10-Q · filed 2023-11-09
-$19.65M
derived: sum of 4 quarters · filed 2024-03-14
2022-06-30-$10.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$15.10M
10-Q · filed 2023-08-08
-$20.19M
derived: sum of 3 quarters · filed 2024-03-14
-$24.58M
derived: sum of 4 quarters · filed 2024-03-14
2022-03-31-$4.72M
10-Q · filed 2023-05-09
-$9.81M
derived: sum of 2 quarters · filed 2024-03-14
-$14.20M
derived: sum of 3 quarters · filed 2024-03-14
-$14.55M
derived: sum of 4 quarters · filed 2024-03-14
2021-12-31-$5.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$9.49M
derived: sum of 2 quarters · filed 2024-03-14
-$9.83M
derived: sum of 3 quarters · filed 2024-03-14
-$7.85M
10-K · filed 2024-03-14
2021-09-30-$4.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$4.74M
derived: sum of 2 quarters · filed 2022-11-08
-$2.76M
10-Q · filed 2022-11-08
$2.03M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30-$346.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.64M
10-Q · filed 2022-08-09
$6.42M
derived: sum of 3 quarters · filed 2023-03-16
$6.17M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$1.98M
10-Q · filed 2022-05-10
$6.77M
derived: sum of 2 quarters · filed 2023-03-16
$6.51M
derived: sum of 3 quarters · filed 2023-03-16
$6.84M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$4.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$4.53M
derived: sum of 2 quarters · filed 2023-03-16
$4.86M
derived: sum of 3 quarters · filed 2023-03-16
$2.17M
10-K · filed 2023-03-16
2020-09-30-$257.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$76.00K
derived: sum of 2 quarters · filed 2021-11-09
-$2.61M
10-Q · filed 2021-11-09
-$2.03M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$333.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$2.35M
10-Q · filed 2021-08-09
-$1.77M
derived: sum of 3 quarters · filed 2022-03-01
-$2.90M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$2.69M
10-Q · filed 2021-05-07
-$2.11M
derived: sum of 2 quarters · filed 2022-03-01
-$3.23M
derived: sum of 3 quarters · filed 2022-03-01
-$6.46M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$579.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$546.00K
derived: sum of 2 quarters · filed 2022-03-01
-$3.78M
derived: sum of 3 quarters · filed 2022-03-01
-$1.43M
10-K · filed 2022-03-01
2019-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$4.36M
derived: sum of 2 quarters · filed 2020-11-09
-$2.01M
10-Q · filed 2020-11-09
-$1.63M
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30-$3.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$883.00K
10-Q · filed 2020-08-10
-$501.00K
derived: sum of 3 quarters · filed 2021-03-16
-$237.00K
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31$2.35M
10-Q · filed 2020-05-11
$2.73M
derived: sum of 2 quarters · filed 2021-03-16
$2.99M
derived: sum of 3 quarters · filed 2021-03-16
$947.00K
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31$382.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$646.00K
derived: sum of 2 quarters · filed 2021-03-16
-$1.40M
derived: sum of 3 quarters · filed 2021-03-16
$113.00K
10-K · filed 2021-03-16
$113.49K
10-K · filed 2019-03-18
2018-09-30$264.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$1.78M
derived: sum of 2 quarters · filed 2019-11-07
-$269.00K
10-Q · filed 2019-11-07
-$269.22K
10-Q · filed 2018-11-07
$236.12K
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$2.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$533.00K
10-Q · filed 2019-08-09
-$533.07K
10-Q · filed 2018-08-09
-$27.88K
derived: sum of 3 quarters · filed 2020-03-16
-$204.69K
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$1.51M
10-Q · filed 2019-05-10
$1.51M
10-Q · filed 2018-05-10
$2.02M
derived: sum of 2 quarters · filed 2020-03-16
$1.84M
derived: sum of 3 quarters · filed 2020-03-16
$3.11M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$505.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$328.31K
derived: sum of 2 quarters · filed 2020-03-16
$1.60M
derived: sum of 3 quarters · filed 2020-03-16
$2.33M
10-K · filed 2020-03-16
$2.33M
10-K · filed 2018-03-16
2017-09-30-$176.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$1.10M
derived: sum of 2 quarters · filed 2018-11-07
$1.82M
10-Q · filed 2018-11-07
$4.87M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$2.00M
10-Q · filed 2018-08-09
$5.04M
derived: sum of 3 quarters · filed 2019-03-18
$4.17M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$728.29K
10-Q · filed 2018-05-10
$3.77M
derived: sum of 2 quarters · filed 2019-03-18
$2.90M
derived: sum of 3 quarters · filed 2019-03-18
$2.92M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$2.17M
derived: sum of 2 quarters · filed 2019-03-18
$2.19M
derived: sum of 3 quarters · filed 2019-03-18
$2.16M
10-K · filed 2019-03-18
2016-09-30-$875.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$854.78K
derived: sum of 2 quarters · filed 2017-11-07
-$887.38K
10-Q · filed 2017-11-07
$283.05K
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$21.15K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
-$11.45K
10-Q · filed 2017-08-07
$1.16M
derived: sum of 3 quarters · filed 2018-03-16
$1.26M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$32.61K
10-Q · filed 2017-05-04
$1.14M
derived: sum of 2 quarters · filed 2018-03-16
$1.24M
derived: sum of 3 quarters · filed 2018-03-16
$574.97K
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$1.27M
derived: sum of 2 quarters · filed 2018-03-16
$607.58K
derived: sum of 3 quarters · filed 2018-03-16
$11.54M
10-K · filed 2018-03-16
2015-09-30$99.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$562.85K
derived: sum of 2 quarters · filed 2016-11-09
$10.37M
10-Q · filed 2016-11-09
$10.71M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$662.17K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$10.27M
10-Q · filed 2016-08-04
$10.61M
derived: sum of 3 quarters · filed 2017-03-16
$8.36M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$10.93M
10-Q · filed 2016-05-09
$11.28M
derived: sum of 2 quarters · filed 2017-03-16
$9.02M
derived: sum of 3 quarters · filed 2017-03-16
$11.59M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$344.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$1.91M
derived: sum of 2 quarters · filed 2017-03-16
$655.93K
derived: sum of 3 quarters · filed 2017-03-16
$685.70K
10-K · filed 2017-03-16
2014-09-30-$2.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$311.27K
derived: sum of 2 quarters · filed 2015-11-04
$341.03K
10-Q · filed 2015-11-04
$465.19K
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03
$2.60M
10-Q · filed 2015-08-03
$2.72M
derived: sum of 3 quarters · filed 2016-03-15
$2.65M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$29.77K
10-Q · filed 2015-05-01
$153.92K
derived: sum of 2 quarters · filed 2016-03-15
$77.27K
derived: sum of 3 quarters · filed 2016-03-15
-$79.09K
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$124.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$47.50K
derived: sum of 2 quarters · filed 2016-03-15
-$108.86K
derived: sum of 3 quarters · filed 2016-03-15
-$183.47K
10-K · filed 2016-03-15
2013-09-30-$76.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
-$233.01K
derived: sum of 2 quarters · filed 2014-10-31
-$307.63K
10-Q · filed 2014-10-31
$307.63K
10-Q · filed 2013-11-08
-$1.57M
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$156.36K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
-$230.98K
10-Q · filed 2014-08-01
$230.98K
10-Q · filed 2013-08-09
-$1.49M
derived: sum of 3 quarters · filed 2015-03-16
-$1.31M
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31-$74.62K
10-Q · filed 2014-05-09
$74.62K
10-Q · filed 2013-05-10
-$1.33M
derived: sum of 2 quarters · filed 2015-03-16
-$1.15M
derived: sum of 3 quarters · filed 2015-03-16
-$988.75K
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31-$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
-$1.08M
derived: sum of 2 quarters · filed 2015-03-16
-$914.13K
derived: sum of 3 quarters · filed 2015-03-16
-$747.98K
10-K · filed 2015-03-16
2012-09-30$182.17K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$345.75K
derived: sum of 2 quarters · filed 2013-11-08
$511.89K
10-Q · filed 2013-11-08
-$511.89K
10-Q · filed 2012-11-07
$868.62K
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30$163.57K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$329.72K
10-Q · filed 2013-08-09
-$329.72K
10-Q · filed 2012-08-08
$686.45K
derived: sum of 3 quarters · filed 2014-03-07
$641.60K
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31$166.15K
10-Q · filed 2013-05-10
-$166.15K
10-Q · filed 2012-05-09
$522.87K
derived: sum of 2 quarters · filed 2014-03-07
$478.03K
derived: sum of 3 quarters · filed 2014-03-07
$587.57K
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31$356.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
$311.88K
derived: sum of 2 quarters · filed 2014-03-07
$421.42K
derived: sum of 3 quarters · filed 2014-03-07
$591.50K
10-K · filed 2014-03-07
2011-09-30-$44.84K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
$64.69K
derived: sum of 2 quarters · filed 2012-11-07
$234.78K
10-Q · filed 2012-11-07
$198.15K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$109.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$279.62K
10-Q · filed 2012-08-08
$242.99K
derived: sum of 3 quarters · filed 2013-03-18
$132.96K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$170.09K
10-Q · filed 2012-05-09
$133.46K
derived: sum of 2 quarters · filed 2013-03-18
$23.42K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$36.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$146.66K
derived: sum of 2 quarters · filed 2013-03-18
$152.22K
10-K · filed 2013-03-18
2010-09-30-$110.03K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$188.85K
10-Q · filed 2011-11-04
2010-06-30$298.88K
10-Q · filed 2011-08-05
2009-12-31$293.56K
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60